About Index Trending news
Lists
Pricing
Viventia Bio Inc.

Viventia Bio Inc.

Viventia Bio Inc.

Viventia Bio is the leader in developing next generation oncology therapeutics utilizing our proprietary Targeted Protein Therapeutic technology (TPT).

Elsewhere

Alexa global traffic share

Acquired by
21 Sep 2016
Eleven Biotherapeutics
2
Locations
HQ
Headquarters
Acquisition
Seeking Alpha , businesswire

Eleven Biotherapeutics acquires Viventia Bio in all-stock deal